Nucleic acids produced by biological methods for vaccine production
The present invention relates to a nucleic acid sequence produced by a biological method comprising two or three primary nucleic acid sequence portions of SARS-CoV-2 and no more than three secondary nucleic acid sequence portions wherein the secondary nucleic acid sequence portions encode an amino a...
Gespeichert in:
Hauptverfasser: | , , , |
---|---|
Format: | Patent |
Sprache: | chi ; eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!